rs879254337
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_000245.4(MET):c.3633-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000245.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- hereditary papillary renal cell carcinomaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- papillary renal cell carcinomaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen
- autosomal recessive nonsyndromic hearing loss 97Inheritance: AR Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- osteofibrous dysplasiaInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- arthrogryposis, distal, IIa 11Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- nonsyndromic genetic hearing lossInheritance: AR Classification: LIMITED Submitted by: ClinGen
- complex neurodevelopmental disorderInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MET | NM_000245.4 | c.3633-2A>G | splice_acceptor_variant, intron_variant | Intron 18 of 20 | ENST00000397752.8 | NP_000236.2 | ||
MET | NM_001127500.3 | c.3687-2A>G | splice_acceptor_variant, intron_variant | Intron 18 of 20 | NP_001120972.1 | |||
MET | NM_001324402.2 | c.2343-2A>G | splice_acceptor_variant, intron_variant | Intron 17 of 19 | NP_001311331.1 | |||
MET | XM_011516223.2 | c.3690-2A>G | splice_acceptor_variant, intron_variant | Intron 19 of 21 | XP_011514525.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MET | ENST00000397752.8 | c.3633-2A>G | splice_acceptor_variant, intron_variant | Intron 18 of 20 | 1 | NM_000245.4 | ENSP00000380860.3 | |||
MET | ENST00000318493.11 | c.3687-2A>G | splice_acceptor_variant, intron_variant | Intron 18 of 20 | 1 | ENSP00000317272.6 | ||||
MET | ENST00000436117.3 | n.*1238-2A>G | splice_acceptor_variant, intron_variant | Intron 17 of 19 | 1 | ENSP00000410980.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Renal cell carcinoma Uncertain:1
This sequence change affects an acceptor splice site in intron 18 of the MET gene. It is expected to disrupt mRNA splicing and likely results in an absent or disrupted protein product. While this particular variant has not been reported in the literature, truncating variants in MET are not necessarily pathogenic (PMID: 9140397), and the clinical significance of this variant is uncertain at this time. In summary, this is a novel variant and without additional functional and/or genetic data, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at